REMAP-CAP is an Adaptive Platform Trial for Community-Acquired Pneumonia. A first video has been launched for a better understanding of the REMAP-CAP trial and how the adaptive platform trial works.
We join our colleagues at BBMRI in remembering Gert-Jan van Ommen.
The General Assembly of the Clinical Research Initiative for Global Health Consortium (CRIGH) went virtual for its 3rd edition.
EOSC-Life (European Open Science Cloud) has launched its first Digital Life Sciences Open Call for projects sharing data, tools and workflows in the cloud.
The Alliance of Medical Research Infrastructures (AMRI) published an article on biomarker research and development for COVID-19 which focuses on the need to coordinate efforts globally and outlines actions that answer 5 strategic objectives set forth by AMRI.
Registration is now open for the EULAC PerMed ELSA Workshop. The workshop aims to share insights on ethical legal and socials issues as they relate to research and implementation of personalised medicine in Europe and in Latin America and the Caribbean.
PedCRIN creates a collection of tools for the setup and management of paediatric and neonatal clinical trials
The need for safe and effective COVID-19 treatments requires the capacity to conduct multinational clinical trials to test and compare existing and new therapies and vaccines.
CONSORT develops a checklist and guidelines for reporting in randomized platform trials (adaptive design)
The Consolidated Standards Of Reporting Trials (CONSORT) group published an extension for the reporting guidelines which takes into consideration the adaptive design of platform trials.
As modern life science research is happening across scientific disciplines, individual scientists, single labs and across country borders, it often lacks some of the expertise required to address all aspects of a research question.
ERIC-Forum published a brief, entitled “Funding models for access to ERIC multinational / transnational services” which focuses on the funding instruments that allow ERICs to provide access to services
Every European citizen is affected by cancer, either directly or indirectly. In that perspective The European Commission wrote the interim report ‘Conquering Cancer: Mission Possible’, aiming to deliver concrete solutions on this matter.
The launch of EU-RESPONSE, a 5-year, €15,7M multinational project, funded by the European Unions’ Horizon 2020 research and innovation program for the design and implementation of a new European adaptive platform trial on COVID-19 is yet another demonstration of the central role that the European
Three Open Innovation Testbed (OITB) projects TBMED, MDOT and SAFE-N-MEDTECH are working together to provide services to accompany innovators with their solutions to fight COVID-19. The COVID-19 pandemic has put SMEs at risk, as a result of the economic slowdown.